Filing Details
- Accession Number:
- 0001209191-20-049832
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-09 16:12:30
- Reporting Period:
- 2020-09-08
- Accepted Time:
- 2020-09-09 16:12:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1725057 | Ceridian Hcm Holding Inc. | CDAY | Services-Prepackaged Software (7372) | 463231686 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1746255 | Erin Leagh Turner | C/O Ceridian Hcm Holding Inc. 3311 East Old Shakopee Road Minneapolis MN 55425 | President And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-08 | 5,000 | $38.63 | 126,611 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-09-08 | 1,125 | $70.37 | 125,486 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-08 | 3,054 | $71.36 | 122,432 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-08 | 821 | $72.62 | 121,611 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to purchase) | Disposition | 2020-09-08 | 5,000 | $0.00 | 5,000 | $38.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 90,000 | 2028-09-04 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to purchase) | $49.93 | 2029-03-20 | 76,335 | 76,335 | Direct | |
| Common Stock | Option (right to purchase) | $65.26 | 2030-05-08 | 187,321 | 187,321 | Direct | |
| Common Stock | Performance Units | $0.00 | 2021-03-01 | 3,382 | 3,382 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2029-03-20 | 76,335 | 76,335 | Direct |
| 2030-05-08 | 187,321 | 187,321 | Direct |
| 2021-03-01 | 3,382 | 3,382 | Direct |
Footnotes
- The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.019 to $70.815 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.05 to $71.97 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.08 to $72.87 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Includes (i) 25,000 shares issuable at the election of the recipient pursuant to vested Restricted Stock Units, granted on September 4, 2018, and 25,000 shares issuable pursuant to Restricted Stock Units that vest in two equal annual installments beginning on September 4, 2021, (ii) 50,000 shares that are issuable pursuant to Restricted Stock Units, granted on September 9, 2019, that vest in four equal annual installments beginning on September 9, 2020, (iii) 1,538 shares that are issuable pursuant to Restricted Stock Units, granted on February 28, 2020, that vest in three annual installments beginning on February 28, 2021, and (iv) 20,073 shares that are issuable pursuant to Restricted Stock Units, granted on May 8, 2020, that vest in three annual installments beginning on May 8, 2021.
- Consists of 45,000 vested and exercisable options as of September 4, 2020, of which 5,000 are being exercised pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, and 50,000 options that vest and become exercisable in two equal annual installments beginning on September 4, 2021.
- Not applicable.
- Consists of 19,083 vested and exercisable options as of March 20, 2020 and 57,252 options that vest and become exercisable in three annual installments beginning on March 20, 2021.
- These options vest and become exercisable in four annual installments beginning on May 8, 2021.
- Each performance unit, granted on February 28, 2020, represents a contingent right to receive up to 1.25 shares of Common Stock. The performance units vest upon satisfaction of Cloud Revenue and Adjusted EBITDA margin targets under the Company's 2020 Management Incentive Plan.
Billionaire Hedge Funds
